Azacitidinas Celgene

Medicinal product

(Invented) name

Azacitidinas Celgene

Active substance (s)

Azacitidinas

Strength

25 mg/ml

Pharmaceutical form

milteliai injekcinei suspensijai

Route (s) of administration

leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01BC07, Azacitidine

Marketing authorisation holder

Celgene Europe BV, Nyderlandai

Date of authorisation

2019-08-02

Date of renewal

Documents

Search in EMA Europe

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10c

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Powder for suspension for injection	1 ml
Azacitidinas	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
102288	88388	1088388	flakonas	N1		Receptinis	EU/1/19/1382/001	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-05-19	Išregistruotas
2019-08-02	Registruotas